Vaccinations Rates in the Elderly with Diabetes Mellitus


Infections are a major cause of morbidity and mortality in the elderly. Improvements in health care prevention including vaccinations and treatment have led to an increase in the birth life expectancy. The vaccines that are now recommended for people over 60 are influenza, herpes zoster and a vaccine combining tetanus toxoid, reduced diphtheria toxoid, and pneumococcal vaccine. Our aim was to estimate the prevelance of vaccination among diabetic patients attending in Tepecik Training Hospital and in Ege University Faculty of Medicine. Patients and Methods: Individuals at or over the age of 60 who were attending to Tepecik Training Hospital and at Ege University Faculty of Medicine. Department of Internal Medicine was targeted from February to May 2014. Our data are collected from the patients face to face by questionnaire. Results: A total of 274 elderly patients with a mean ± SD (range) age of 72 ± 6 (62 - 93) years were questioned. The vaccination ratios were determined as 34% (93) for influenza, 9.5% (26) for pneumococcal, 10.6% (27) for tetanus vaccine. The patients were divided in two groups as diabetics and non-diabetics. The influenza vaccination rate is 38.1% in diabetic patients, rate of 31.8% in non-diabetic patients, the pneumococcal vaccine rate is 13.4% in diabetic patients, rate of 7.39% in non-diabetic patients. The tetanus vaccination rate is 9.28% in diabetic patients, rate of 11.36% in non-diabetic patients. No statistically significant difference between two groups was determined.

Share and Cite:

Sahin, S. , Tasar, P. , Guclu, Y. , Sengul, H. , Bozkurt, N. , Garip, A. , Duman, S. and Akcicek, F. (2014) Vaccinations Rates in the Elderly with Diabetes Mellitus. Advances in Aging Research, 3, 293-296. doi: 10.4236/aar.2014.34038.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Recommended Adult Immunization Schedule United States (2013) Clinical Guideline.
[2] Asilamalar, K.S., Infeksiyonlar, Y., Kose, S., Yalcin, A.N. and Erbay, R.H. (2013) Bulasici Hastaliklari Onleme Dernegi Yayinlari. No. 2, 343-352.
[3] Goronzy, J.J. and Weyand, C.M. (2013) Understanding Immunosenescence to Improve Responses to Vaccines. Nature Immunology, 14, 428-436.
[4] Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. (2010) Global Estimates of the Prevalence of Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4-14.
[5] Satman, I., et al. (2013) Twelve-Year Trends in the Prevalence and Risk Factors of Diabetes and Prediabetes in Turkish Adults. European Journal of Epidemiology, 28, 169-180.
[6] Kirkman, M.S., et al. (2012) Diabetes in Older Adults. Diabetes Care, 35, 2650-2664.
[7] Centers for Disease Control and Prevention (2011) National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. US Department of Health and Human Services, Atlanta.
[8] Delamaire, M., et al. (1997) Impaired Leucocyte Functions in Diabetic Patients. Diabetic Medicine, 14, 29-34.<29::AID-DIA300>3.0.CO;2-V
[9] Bertoni, A.G., Saydah, S. and Brancati, F.L. (2001) Diabetes and the Risk of Infection-Related Mortality in the US. Diabetes Care, 24, 1044-1049.
[10] Wahid, S.T., et al. (2001) Audit of Influenza and Pneumococcal Vaccination Uptake in Diabetic Patients Attending Secondary Care in the Northern Region. Diabetic Medicine, 18, 599-603.
[11] Egede, L.E. (20003) Association between Number of Physician Visits and Influenza Vaccination Coverage among Diabetic Adults with Access to Care. Diabetes Care, 26, 2562-2567.
[12] Fiore, A.E., Uyeki, T.M., Broder, K., Finelli, L., Euler, G.L., Singleton, J.A., Iskander, J.K., Wortley, P.M., Shay, D.K., Bresee, J.S. and Cox, N.J. (2010) Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports, 59, Centers for Disease Control and Prevention (CDC), 1-62.
[13] Centers for Disease Control and Prevention (1997) Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports, 46, 1-25.
[14] Centers for Disease Control and Prevention (2005) Estimated Influenza Vaccination Coverage among Adults and Children—United States. MMWR Morbidity and Mortality Weekly Report, 54, 304-307.
[15] Koziel, H. and Koziel, M.J. (1995) Pulmonary Complications of Diabetes Mellitus. Pneumonia. Infectious Disease Clinics of North America, 9, 65-96.
[16] Smith, S.A. and Poland, G.A. (2000) Use of Influenza and Pneumococcal Vaccines in People with Diabetes. Diabetes Care, 23, 95-108.
[17] Lu, P.J. and Nuorti, J.P. (2010) Pneumococcal Polysaccharide Vaccination among Adults Aged 65 Years and Older, U.S., 1989-2008. American Journal of Preventive Medicine, 39, 287-295.
[18] Zeybek, Y. (2004) Vaccination in the Sixty-Five and over Age Adults. Turkish Journal of Geriatrics, 7, 152-154.
[19] Environics Research Group (2006) Canadian Adult National Immunization Coverage Survey. Public Health Agency of Canada, Ottawa.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.